31. Stocks rated 2 to 2 . 5 underperformed the S & AMP; P by 3 . 7 percentage points.32. Biogen declined $ 3.32 to $ 42.91 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral. 33. Maryland stocks fell, dragged down by shares of Mid Atlantic Medical Services Inc ., whose stock rating was downgraded. 34. Decliners included ChevronTexaco, which slipped 11 cents to $ 74.94, after Deutsche Securities lowered the oil company's stock rating . 35. Biogen declined $ 3.67 to $ 42.56 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral. 36. Biogen declined $ 1.97 to $ 44.26 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral. 37. Conigliaro remains positive about the company's prospects, initiating a stock rating of " market outperform " two days ago. 38. Morgan Stanley Dean Witter analyst Rebecca Runkle wrote in a report Thursday, downgrading the stock rating to neutral from outperform. 39. Its preferred stock rating and shelf registration for preferred stock were cut to " ba3 " from " ba1 ." 40. Intel Corp .'s estimated earnings for 1998 and its stock rating were cut by UBS Securities, cable channel CNBC reported.
